Case Control Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Mar 7, 2020; 26(9): 933-946
Published online Mar 7, 2020. doi: 10.3748/wjg.v26.i9.933
Figure 6
Figure 6 MiR-182 targeted inhibition of reversion-inducing-cysteine-rich protein with kazal motifs expression. A: MicroRNA 182 (miR-182) had binding sites with reversion-inducing-cysteine-rich protein with kazal motifs (RECK) mRNA; B and C: Double luciferase reporter gene assay verified the targeting relationship between miR-182 and RECK; D: MiR-182 was negatively correlated with RECK protein. NC: Negative control.